Yi He

2.6k total citations
88 papers, 1.9k citations indexed

About

Yi He is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Yi He has authored 88 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Rheumatology, 31 papers in Molecular Biology and 29 papers in Immunology. Recurrent topics in Yi He's work include Osteoarthritis Treatment and Mechanisms (28 papers), Cell Adhesion Molecules Research (20 papers) and Inflammatory mediators and NSAID effects (15 papers). Yi He is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (28 papers), Cell Adhesion Molecules Research (20 papers) and Inflammatory mediators and NSAID effects (15 papers). Yi He collaborates with scholars based in China, Denmark and United States. Yi He's co-authors include Erwei Sun, M.A. Karsdal, Anne‐Christine Bay‐Jensen, Fangyuan Yang, Zeqing Zhai, Yunyun Luo, Dovilė Sinkevičiūtė, Patrik Önnerfjord, Jiaochan Han and Ali Mobasheri and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yi He

82 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi He China 25 707 649 486 234 211 88 1.9k
Christos Chadjichristos France 30 1.3k 1.8× 497 0.8× 422 0.9× 264 1.1× 176 0.8× 66 2.5k
Harini Raghu United States 11 558 0.8× 1.0k 1.6× 288 0.6× 217 0.9× 383 1.8× 16 1.8k
P.L. van Lent Netherlands 24 802 1.1× 916 1.4× 562 1.2× 178 0.8× 287 1.4× 50 1.9k
Hae‐Rim Kim South Korea 26 600 0.8× 814 1.3× 695 1.4× 247 1.1× 111 0.5× 128 2.1k
Hiroaki Matsuno Japan 31 636 0.9× 984 1.5× 593 1.2× 415 1.8× 147 0.7× 100 2.4k
Jing Luo China 26 856 1.2× 403 0.6× 651 1.3× 155 0.7× 144 0.7× 113 2.2k
Qinlong Zheng Denmark 23 457 0.6× 391 0.6× 204 0.4× 210 0.9× 117 0.6× 46 1.6k
Chin‐Jung Hsu Taiwan 28 720 1.0× 348 0.5× 317 0.7× 377 1.6× 140 0.7× 62 1.8k
Monika Biniecka Ireland 23 952 1.3× 849 1.3× 672 1.4× 125 0.5× 73 0.3× 42 2.4k

Countries citing papers authored by Yi He

Since Specialization
Citations

This map shows the geographic impact of Yi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi He more than expected).

Fields of papers citing papers by Yi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi He. The network helps show where Yi He may publish in the future.

Co-authorship network of co-authors of Yi He

This figure shows the co-authorship network connecting the top 25 collaborators of Yi He. A scholar is included among the top collaborators of Yi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi He. Yi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Wujin, et al.. (2025). Safety Evaluation of Human-Derived Uric Acid Degrading Lacticaseibacillus paracasei M2a and Its Impact on Gut Microbiota. Probiotics and Antimicrobial Proteins. 18(1). 775–787. 1 indexed citations
3.
Zheng, Jia, Wei Zhang, Linfeng Li, et al.. (2024). Design, synthesis and anticancer activity of β-carboline based pseudo-natural products by inhibiting AKT/mTOR signaling pathway. Bioorganic Chemistry. 151. 107648–107648. 7 indexed citations
4.
Li, Yingfei, Yi He, Fangyuan Yang, et al.. (2024). Gasdermin E-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation. British Journal of Dermatology. 191(3). 385–396. 11 indexed citations
5.
He, Yi, Walter P. Maksymowych, Stephanie Wichuk, et al.. (2023). A novel biomarker of MMP-cleaved cartilage intermediate layer protein-1 is elevated in patients with rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. Scientific Reports. 13(1). 21717–21717. 6 indexed citations
6.
Luo, Guihu, Yi He, Fangyuan Yang, et al.. (2022). Blocking GSDME-mediated pyroptosis in renal tubular epithelial cells alleviates disease activity in lupus mice. Cell Death Discovery. 8(1). 113–113. 15 indexed citations
7.
Zhuang, Lili, et al.. (2022). Polydatin protects against gouty nephropathy by inhibiting renal tubular cell pyroptosis. International Journal of Rheumatic Diseases. 26(1). 116–123. 7 indexed citations
8.
Zhuang, Lili, Xiaoqing Luo, Yanan Zhang, et al.. (2022). Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis. Cell Death Discovery. 8(1). 27 indexed citations
9.
Zhai, Zeqing, Fangyuan Yang, Wenchao Xu, et al.. (2021). Attenuation of Rheumatoid Arthritis Through the Inhibition of Tumor Necrosis Factor–Induced Caspase 3/Gasdermin E–Mediated Pyroptosis. Arthritis & Rheumatology. 74(3). 427–440. 103 indexed citations
10.
Bay‐Jensen, Anne‐Christine, Angela A. Manginelli, M.A. Karsdal, et al.. (2021). A low repair endotype is predictive for response to FGF-18 treatment: data from the phase II oa forward study. Osteoarthritis and Cartilage. 29. S144–S144. 2 indexed citations
11.
He, Yi, et al.. (2021). A novel PAR2 chemiluminescence immunoassay as a biomarker for arthritic diseases. Osteoarthritis and Cartilage. 29. S155–S155. 1 indexed citations
12.
Luo, Yunyun, Jonathan Samuels, Svetlana Krasnokutsky, et al.. (2021). A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis. Journal of Orthopaedics and Traumatology. 22(1). 10–10. 31 indexed citations
13.
Jie, Hongyu, Yong Wu, Xinai Han, et al.. (2020). Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity. Arthritis Research & Therapy. 22(1). 239–239. 14 indexed citations
14.
Zhuang, Jian, Haiyan Cui, Lili Zhuang, et al.. (2020). Bronchial epithelial pyroptosis promotes airway inflammation in a murine model of toluene diisocyanate-induced asthma. Biomedicine & Pharmacotherapy. 125. 109925–109925. 69 indexed citations
15.
Yang, Fangyuan, Yi He, Zeqing Zhai, & Erwei Sun. (2019). Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus. Journal of Immunology Research. 2019. 1–13. 66 indexed citations
16.
He, Yi, et al.. (2019). Relationship between Vitamin D levels and pain and disease activity in patients with newly diagnosed axial spondyloarthritis. International Journal of Nursing Sciences. 7(1). 54–59. 7 indexed citations
17.
18.
He, Yi, Fangyuan Yang, Guihu Luo, et al.. (2018). Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation. Arthritis Research & Therapy. 20(1). 254–254. 30 indexed citations
19.
He, Yi, Tina Manon‐Jensen, Lars Arendt‐Nielsen, et al.. (2018). A biomarker of hypertrophic chondrocytes, type X collagen, completely distinguishes between OA and RA. Osteoarthritis and Cartilage. 26. S175–S176. 1 indexed citations
20.
He, Yi, Qiusheng Zheng, Man‐Xi Jiang, et al.. (2014). The effect of protease inhibitors on the indcution of osteoarthritis-related biomarkers in bovine full-depth cartilage explants. Osteoarthritis and Cartilage. 22. S172–S172. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christos Chadjichristos Breakdown of academic impact, for papers by Harini Raghu Breakdown of academic impact, for papers by P.L. van Lent Breakdown of academic impact, for papers by Hae‐Rim Kim Breakdown of academic impact, for papers by Hiroaki Matsuno Breakdown of academic impact, for papers by Jing Luo Breakdown of academic impact, for papers by Qinlong Zheng Breakdown of academic impact, for papers by Chin‐Jung Hsu Breakdown of academic impact, for papers by Monika Biniecka
Rankless by CCL
2026